Generic Drugs Market Size, Share, Growth & Industry Analysis, By Application (Cardiovascular Products, Anti-infective Drugs, Anti-arthritis Drugs, Central Nervous System Drugs and Others), By Route of Administration (Oral, Topical, Injectable, and Others), By Distribution Channel, and Regional Analysis, 2024-2031

TABLE OF CONTENT

1 INTRODUCTION OF THE GLOBAL GENERIC DRUGS MARKET 
1.1 Market Definition
1.2 Market Segmentation
1.3 Research Timelines
1.4 Limitations
1.5 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY
3.1 Data Collection
3.1.1 Secondary Sources
3.1.2 Primary Sources
3.1.3 Research Flow
3.2 Subject Matter Expert Advice
3.3 Quality Check
3.4 Final Review
3.5 Bottom-Up Approach
3.6 Top-down Approach

4 GLOBAL GENERIC DRUGS MARKET OUTLOOK
4.1 Market Evolution
4.2 Overview
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.3.4 Challenges
4.4 Pricing Analysis
4.5 Porter’s Five Forces Analysis
4.6 Value Chain Analysis
4.7 Macroeconomic Analysis

5 IMPACT OF RUSSIA-UKRAINE WAR

6 GLOBAL GENERIC DRUGS MARKET, BY APPLICATION
6.1 Overview
6.2 Cardiovascular Products
6.3 Anti-infective Drugs
6.4  Anti-arthritis Drugs
6.5 Central Nervous System Drugs
6.6 Anti-cancer Drugs
6.7 Respiratory Products
6.8 Other Applications (Gastrointestinal, Hormonal Drug) 

7 GLOBAL GENERIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION
7.1 Overview
7.2 Oral
7.3 Topical
7.4 Injectable
7.5 Other Routes of Administration (Sublingual, Rectal) 

8 GLOBAL GENERIC DRUGS MARKET, BY DISTRIBUTION CHANNEL
8.1 Overview
8.2 Hospitals & Clinics
8.3 Retail Pharmacies/ Pharmacy Drug Store
8.4 Online Retail 

9 GLOBAL GENERIC DRUGS MARKET, BY GEOGRAPHY
9.1 Overview

10 NORTH AMERICA 
10.1 U.S.
10.2 Canada
10.3 Mexico

11 EUROPE 
11.1 Germany
11.2 U.K.
11.3 France
11.4 Italy
11.5 Spain
11.6 Russia
11.7 Rest of Europe

12 ASIA-PACIFIC 
12.1 China
12.2 Japan
12.3 India
12.4 South Korea
12.5 Rest of Asia-Pacific

13 MIDDLE EAST & AFRICA 
13.1 GCC
13.2 South Africa
13.3 North Africa
13.4 Rest of Middle East & Africa

14 LATIN AMERICA 
14.1 Brazil
14.2 Argentina
14.3 Rest of South America

15  GLOBAL GENERIC DRUGS MARKET COMPETITIVE LANDSCAPE
15.1 Overview
15.2 Key Developments
15.3 Key Strategic Developments
15.4 Company Market Ranking
15.5 Regional Footprint
15.6 Industry Footprint

16 COMPANY PROFILES
16.1 Viatris Inc
16.1.1 Key Facts
16.1.2 Financial Overview
16.1.3 Product Benchmarking
16.1.4 Recent Developments
16.1.5 Winning Imperatives
16.1.6 Current Focus & Strategies
16.1.7 Threat from competition
16.1.8 SWOT Analysis
16.2 Abbott 
16.2.1 Key Facts
16.2.2 Financial Overview
16.2.3 Product Benchmarking
16.2.4 Recent Developments
16.2.5 Winning Imperatives
16.2.6 Current Focus & Strategies
16.2.7 Threat from competition
16.2.8 SWOT Analysis
16.3 Teva Pharmaceutical Industries Limited
16.3.1 Key Facts
16.3.2 Financial Overview
16.3.3 Product Benchmarking
16.3.4 Recent Developments
16.3.5 Winning Imperatives
16.3.6 Current Focus & Strategies
16.3.7 Threat from competition
16.3.8 SWOT Analysis
16.4 Sun Pharmaceutical Industries Ltd.
16.4.1 Key Facts
16.4.2 Financial Overview
16.4.3 Product Benchmarking
16.4.4 Recent Developments
16.4.5 Winning Imperatives
16.4.6 Current Focus & Strategies
16.4.7 Threat from competition
16.4.8 SWOT Analysis
16.5 STADA Arzneimittel AG
16.5.1 Key Facts
16.5.2 Financial Overview
16.5.3 Product Benchmarking
16.5.4 Recent Developments
16.5.5 Winning Imperatives
16.5.6 Current Focus & Strategies
16.5.7 Threat from competition
16.5.8 SWOT Analysis
16.6 GlaxoSmithKline PLC
16.6.1 Key Facts
16.6.2 Financial Overview
16.6.3 Product Benchmarking
16.6.4 Recent Developments
16.6.5 Winning Imperatives
16.6.6 Current Focus & Strategies
16.6.7 Threat from competition
16.6.8 SWOT Analysis
16.7 Baxter
16.7.1 Key Facts
16.7.2 Financial Overview
16.7.3 Product Benchmarking
16.7.4 Recent Developments
16.7.5 Winning Imperatives
16.7.6 Current Focus & Strategies
16.7.7 Threat from competition
16.7.8 SWOT Analysis
16.8 Pfizer Inc.
16.8.1 Key Facts
16.8.2 Financial Overview
16.8.3 Product Benchmarking
16.8.4 Recent Developments
16.8.5 Winning Imperatives
16.8.6 Current Focus & Strategies
16.8.7 Threat from competition
16.8.8 SWOT Analysis
16.9 Sanofi
16.9.1 Key Facts
16.9.2 Financial Overview
16.9.3 Product Benchmarking
16.9.4 Recent Developments
16.9.5 Winning Imperatives
16.9.6 Current Focus & Strategies
16.9.7 Threat from competition
16.9.8 SWOT Analysis
16.10 Novartis AG (Sandoz International)
16.10.1 Key Facts
16.10.2 Financial Overview
16.10.3 Product Benchmarking
16.10.4 Recent Developments
16.10.5 Winning Imperatives
16.10.6 Current Focus & Strategies
16.10.7 Threat from competition
16.10.8 SWOT Analysis

LIST OF TABLES 

TABLE 1 Global Generic Drugs Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 2 Global Generic Drugs Market Revenue, By Route of Administration, 2021 – 2031 (USD Billion)
TABLE 3 Global Generic Drugs Market Revenue, By Distribution Channel, 2021 – 2031 (USD Billion)
TABLE 4 Global Generic Drugs Market Revenue, By Geography, 2021 – 2031 (USD Billion)
TABLE 5 North America Generic Drugs Market Revenue, By Country, 2021 – 2031 (USD Billion)
TABLE 6 North America Generic Drugs Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 7 North America Generic Drugs Market Revenue, By Route of Administration, 2021 – 2031 (USD Billion)
TABLE 8 North America Generic Drugs Market Revenue, By Distribution Channel, 2021 – 2031 (USD Billion)
TABLE 9 US Generic Drugs Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 10 US Generic Drugs Market Revenue, By Route of Administration, 2021 – 2031 (USD Billion)
TABLE 11 US Generic Drugs Market Revenue, By Distribution Channel, 2021 – 2031 (USD Billion)
TABLE 12 Canada Generic Drugs Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 13 Canada Generic Drugs Market Revenue, By Route of Administration, 2021 – 2031 (USD Billion)
TABLE 14 Canada Generic Drugs Market Revenue, By Distribution Channel, 2021 – 2031 (USD Billion)
TABLE 15 Mexico Generic Drugs Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 16 Mexico Generic Drugs Market Revenue, By Route of Administration, 2021 – 2031 (USD Billion)
TABLE 17 Mexico Generic Drugs Market Revenue, By Distribution Channel, 2021 – 2031 (USD Billion)
TABLE 18 Europe Generic Drugs Market Revenue, By Country, 2021 – 2031 (USD Billion)
TABLE 19 Europe Generic Drugs Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 20 Europe Generic Drugs Market Revenue, By Route of Administration, 2021 – 2031 (USD Billion)
TABLE 21 Europe Generic Drugs Market Revenue, By Distribution Channel, 2021 – 2031 (USD Billion)
TABLE 22 Germany Generic Drugs Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 23 Germany Generic Drugs Market Revenue, By Route of Administration, 2021 – 2031 (USD Billion)
TABLE 24 Germany Generic Drugs Market Revenue, By Distribution Channel, 2021 – 2031 (USD Billion)
TABLE 25 France Generic Drugs Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 26 France Generic Drugs Market Revenue, By Route of Administration, 2021 – 2031 (USD Billion)
TABLE 27 France Generic Drugs Market Revenue, By Distribution Channel, 2021 – 2031 (USD Billion)
TABLE 28 U.K. Generic Drugs Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 29 U.K. Generic Drugs Market Revenue, By Route of Administration, 2021 – 2031 (USD Billion)
TABLE 30 U.K. Generic Drugs Market Revenue, By Distribution Channel, 2021 – 2031 (USD Billion)
TABLE 31 Spain Generic Drugs Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 32 Spain Generic Drugs Market Revenue, By Route of Administration, 2021 – 2031 (USD Billion)
TABLE 33 Spain Generic Drugs Market Revenue, By Distribution Channel, 2021 – 2031 (USD Billion)
TABLE 34 Italy Generic Drugs Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 35 Italy Generic Drugs Market Revenue, By Route of Administration, 2021 – 2031 (USD Billion)
TABLE 36 Italy Generic Drugs Market Revenue, By Distribution Channel, 2021 – 2031 (USD Billion)
TABLE 37 Russia Generic Drugs Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 38 Russia Generic Drugs Market Revenue, By Route of Administration, 2021 – 2031 (USD Billion)
TABLE 39 Russia Generic Drugs Market Revenue, By Distribution Channel, 2021 – 2031 (USD Billion)
TABLE 40 Rest of Europe Generic Drugs Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 41 Rest of Europe Generic Drugs Market Revenue, By Route of Administration, 2021 – 2031 (USD Billion)
TABLE 42 Rest of Europe Generic Drugs Market Revenue, By Distribution Channel, 2021 – 2031 (USD Billion)
TABLE 43 Asia-Pacific Generic Drugs Market Revenue, By Country, 2021 – 2031 (USD Billion)
TABLE 44 Asia-Pacific Generic Drugs Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 45 Asia-Pacific Generic Drugs Market Revenue, By Route of Administration, 2021 – 2031 (USD Billion)
TABLE 46 Asia-Pacific Generic Drugs Market Revenue, By Distribution Channel, 2021 – 2031 (USD Billion)
TABLE 47 China Generic Drugs Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 48 China Generic Drugs Market Revenue, By Route of Administration, 2021 – 2031 (USD Billion)
TABLE 49 China Generic Drugs Market Revenue, By Distribution Channel, 2021 – 2031 (USD Billion)
TABLE 50 Japan Generic Drugs Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 51 Japan Generic Drugs Market Revenue, By Route of Administration, 2021 – 2031 (USD Billion)
TABLE 52 Japan Generic Drugs Market Revenue, By Distribution Channel, 2021 – 2031 (USD Billion)
TABLE 53 India Generic Drugs Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 54 India Generic Drugs Market Revenue, By Route of Administration, 2021 – 2031 (USD Billion)
TABLE 55 India Generic Drugs Market Revenue, By Distribution Channel, 2021 – 2031 (USD Billion)
TABLE 56 South Korea Generic Drugs Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 57 South Korea Generic Drugs Market Revenue, By Route of Administration, 2021 – 2031 (USD Billion)
TABLE 58 South Korea Generic Drugs Market Revenue, By Distribution Channel, 2021 – 2031 (USD Billion)
TABLE 59 Rest of Asia-Pacific Generic Drugs Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 60 Rest of Asia-Pacific Generic Drugs Market Revenue, By Route of Administration, 2021 – 2031 (USD Billion)
TABLE 61 Rest of Asia-Pacific Generic Drugs Market Revenue, By Distribution Channel, 2021 – 2031 (USD Billion)
TABLE 62 Middle East and Africa Generic Drugs Market Revenue, By Country, 2021 – 2031 (USD Billion)
TABLE 63 Middle East and Africa Generic Drugs Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 64 Middle East and Africa Generic Drugs Market Revenue, By Route of Administration, 2021 – 2031 (USD Billion)
TABLE 65 Middle East and Africa Generic Drugs Market Revenue, By Distribution Channel, 2021 – 2031 (USD Billion)
TABLE 66 GCC Generic Drugs Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 67 GCC Generic Drugs Market Revenue, By Route of Administration, 2021 – 2031 (USD Billion)
TABLE 68 GCC Generic Drugs Market Revenue, By Distribution Channel, 2021 – 2031 (USD Billion)
TABLE 69 North Africa Generic Drugs Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 70 North Africa Generic Drugs Market Revenue, By Route of Administration, 2021 – 2031 (USD Billion)
TABLE 71 North Africa Generic Drugs Market Revenue, By Distribution Channel, 2021 – 2031 (USD Billion)
TABLE 72 South Africa Generic Drugs Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 73 South Africa Generic Drugs Market Revenue, By Route of Administration, 2021 – 2031 (USD Billion)
TABLE 74 South Africa Generic Drugs Market Revenue, By Distribution Channel, 2021 – 2031 (USD Billion)
TABLE 75 Rest of Middle East & Africa Generic Drugs Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 76 Rest of Middle East & Africa Generic Drugs Market Revenue, By Route of Administration, 2021 – 2031 (USD Billion)
TABLE 77 Rest of Middle East & Africa Generic Drugs Market Revenue, By Distribution Channel, 2021 – 2031 (USD Billion)
TABLE 78 Latin America Generic Drugs Market Revenue, By Country, 2021 – 2031 (USD Billion)
TABLE 79 Latin America Generic Drugs Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 80 Latin America Generic Drugs Market Revenue, By Route of Administration, 2021 – 2031 (USD Billion)
TABLE 81 Latin America Generic Drugs Market Revenue, By Distribution Channel, 2021 – 2031 (USD Billion)
TABLE 82 Brazil Generic Drugs Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 83 Brazil Generic Drugs Market Revenue, By Route of Administration, 2021 – 2031 (USD Billion)
TABLE 84 Brazil Generic Drugs Market Revenue, By Distribution Channel, 2021 – 2031 (USD Billion)
TABLE 85 Argentina Generic Drugs Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 86 Argentina Generic Drugs Market Revenue, By Route of Administration, 2021 – 2031 (USD Billion)
TABLE 87 Argentina Generic Drugs Market Revenue, By Distribution Channel, 2021 – 2031 (USD Billion)
TABLE 88 Rest of Latin America Generic Drugs Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 89 Rest of Latin America Generic Drugs Market Revenue, By Route of Administration, 2021 – 2031 (USD Billion)
TABLE 90 Rest of Latin America Generic Drugs Market Revenue, By Distribution Channel, 2021 – 2031 (USD Billion)
TABLE 91 Company Market Ranking
TABLE 92 Regional Footprint
TABLE 93 Product Benchmarking
TABLE 94 Recent Developments
TABLE 95 Winning Imperatives

LIST OF FIGURES 

FIG. 1 Market Segmentation
FIG. 2 Research Timeline
FIG. 3 Global Generic Drugs Market 2021-2031 (USD Billion)
FIG. 4 Global Generic Drugs Market Geographical Analysis (CAGR %)
FIG. 5 Global Generic Drugs Absolute Market Opportunity (USD Billion)
FIG. 6 Global Generic Drugs Market Attractiveness (USD Billion)
FIG. 7 Global Generic Drugs Market, By Application, 2021-2031 (USD Billion)
FIG. 8 Global Generic Drugs Market, By Route of Administration, 2021-2031 (USD Billion)
FIG. 9 Global Generic Drugs Market, By Distribution Channel, 2021-2031 (USD Billion)
FIG. 10 Research Methodology
FIG. 11 Research Process
FIG. 12 Bottom-Up Approach
FIG. 13 Top-Bottom Approach
FIG. 14 Market Dynamics Overview
FIG. 15 Porter's Five Forces Analysis
FIG. 16 Value Chain Analysis
FIG. 17 Macroeconomic Analysis
FIG. 18 Global Generic Drugs Market Revenue Share, By Application, 2023 and 2031 (%)
FIG. 19 Global Generic Drugs Market Revenue Share, By Route of Administration, 2023 and 2031 (%)
FIG. 20 Global Generic Drugs Market Revenue Share, By Distribution Channel, 2023 and 2031 (%)
FIG. 21 Global Generic Drugs Market Revenue Share, By Geographic Regions, 2023 and 2031 (%)
FIG. 22 Market Size and Projections, 2021 - 2031 (USD Billion)
FIG. 23 North America Generic Drugs Market Overview Share, By Countries, 2021 – 2031 (%)
FIG. 24 Market Size and Projections, 2021 - 2031 (USD Billion)
FIG. 25 Europe Generic Drugs Market Overview Share, By Countries, 2021 – 2031 (%)
FIG. 26 Market Size and Projections, 2021 - 2031 (USD Billion)
FIG. 27 Asia-Pacific Generic Drugs Market Overview Share, By Countries, 2021 – 2031 (%)
FIG. 28 Market Size and Projections, 2021 - 2031 (USD Billion)
FIG. 29 Middle East & Africa Generic Drugs Market Overview Share, By Countries, 2021 – 2031 (%)
FIG. 30 Market Size and Projections, 2021 - 2031 (USD Billion)
FIG. 31 Latin America Generic Drugs Market Overview Share, By Countries, 2021 – 2031 (%)
FIG. 32 Key Strategic Development
FIG. 33 Key Facts
FIG. 34 Financial Overview
FIG. 35 SWOT Analysis